MTNB
Matinas BioPharma Holdings Inc
NYSE MKT: MTNB · HEALTHCARE · BIOTECHNOLOGY
$0.61
+2.87% today
Updated 2026-04-29
Market cap
$3.91M
P/E ratio
—
P/S ratio
34.81x
EPS (TTM)
$-2.00
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Matinas BioPharma Holdings Inc (MTNB) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.00 | $194494.00 | $0.00 | $149687.00 | $119750.00 | $89812.00 | $158333.00 | $33000.00 | $3.19M | $1.10M | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | -100.0% | — | -20.0% | -25.0% | +76.3% | -79.2% | +9560.6% | -65.6% | -100.0% | — |
| Cost of revenue | — | — | $5.18M | $5.29M | $52644.00 | $9.01M | $6.79M | $11.23M | $14.36M | $14.58M | $16.68M | $14.49M | $972000.00 | — |
| Gross profit | — | — | $-5.18M | $-5.10M | $-52644.00 | $-8.86M | $-6.67M | $-11.14M | $-14.20M | $-14.55M | $-13.49M | $1.10M | $-972000.00 | — |
| Gross margin | — | — | — | -2621.0% | — | -5919.6% | -5568.0% | -12409.0% | -8968.8% | -44090.9% | -423.1% | 100.0% | — | — |
| R&D | $78846.00 | $1.76M | $5.18M | $5.29M | $3.95M | $9.01M | $6.79M | $11.23M | $14.36M | $14.58M | $16.68M | $14.49M | $11.43M | $85000.00 |
| SG&A | $37229.00 | $1.95M | $5.29M | $4.81M | $4.31M | $7.64M | $7.98M | $7.78M | $10.01M | $10.19M | $11.10M | $10.37M | $8.73M | $6.88M |
| Operating income | $-116075.00 | $-3.71M | $-10.46M | $-9.91M | $-8.26M | $-16.50M | $-14.65M | $-18.92M | $-24.21M | $-24.73M | $-24.59M | $-23.77M | $-24.59M | $-6.96M |
| Operating margin | — | — | — | -5096.0% | — | -11024.6% | -12230.9% | -21067.4% | -15288.4% | -74954.5% | -771.3% | -2168.4% | — | — |
| EBITDA | — | $-3.71M | $-10.42M | $-9.87M | $-8.20M | $-16.40M | $-14.43M | $-18.59M | $-23.92M | $-24.45M | $-24.23M | $-22.82M | $-19.19M | $-6.50M |
| EBITDA margin | — | — | — | -5073.7% | — | -10957.4% | -12048.6% | -20701.3% | -15105.2% | -74106.1% | -760.2% | -2082.6% | — | — |
| EBIT | — | $-3.71M | $-10.46M | $-9.91M | $-8.26M | $-16.50M | $-14.65M | $-18.92M | $-24.21M | $-24.73M | $-24.59M | $-23.77M | $-20.16M | $-6.96M |
| Interest expense | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.45M | $3.59M | — | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-116075.00 | $-3.71M | $-10.22M | $-9.14M | $-7.60M | $-15.49M | $-14.08M | $-17.37M | $-22.45M | $-23.28M | $-21.00M | $-22.94M | $-24.25M | $-10.35M |
| Net income growth (YoY) | — | -3098.9% | -175.3% | +10.6% | +16.8% | -103.8% | +9.1% | -23.4% | -29.2% | -3.7% | +9.8% | -9.3% | -5.7% | +57.3% |
| Profit margin | — | — | — | -4697.0% | — | -10345.9% | -11760.4% | -19343.4% | -14177.0% | -70554.5% | -658.6% | -2093.2% | — | — |